Search results
People also ask
Who is clearmind biomedical?
Does clearmind biomedical's axonpen system work in Taiwan?
Does clearmind biomedical have a neuroendoscope?
What is the clearmind vision?
Axonpen System. Clearpath. Neuroblade System. Clearmind Biomedical create micro-invasive technology, Axonpen, to safely remove the brain hemorrhage, decreases the operation time, blood loss, and patients can survive and recovery better.
- ABOUT
We know we can help more patients! Clearmind Biomedical...
- PRODUCT
Clearmind Biomedical create micro-invasive technology,...
- MEDIA PRESS
The ClearMind vision is to save lives and help patients...
- CONTACT
ClearMind Biomedical Inc. + 886 2-22697417....
- History
• 510(K) cleared for Axonpen System • Start FIM clinical...
- Team
BIOMEDICAL. HOME. ABOUT. History; Team; PRODUCT. Axonpen...
- Neuroblade System
Clearmind. Solution. 5% Mortality. 6% Morbidity. 2%...
- ABOUT
We know we can help more patients! Clearmind Biomedical create micro-invasive technology, Axonpen, to safely remove the brain hemorrhage, decreases the operation time, blood loss, and patients can survive and recovery better.
Clearmind Biomedical Inc. | LinkedIn. Medical Equipment Manufacturing. Providing innovative technologies in neurosurgical field. View all 9 employees. About us. Established in 2014, ClearMind...
Clearmind develops novel psychedelic medicines to solve widespread—yet under-served—health problems. With a strong medical management and IP-protected treatments, we can better the lives of millions.
Clearmind. Solution. 5% Mortality. 6% Morbidity. 2% Rebleeding. Clearmind Biomedical create micro-invasive technology, Axonpen, to safely remove the brain hemorrhage, decreases the operation time, blood loss, and patients can survive and recovery better.
Jan 11, 2021 · LOS ANGELES, Jan. 11, 2021 /PRNewswire/ -- ClearMind Biomedical has received FDA clearance for its novel neuroendoscope, the Axonpen System, for illumination and visualization of intracranial...
Jul 6, 2022 · Published: Jul 06, 2022. NEW TAIPEI CITY, Taiwan, July 6, 2022 /PRNewswire/ -- ClearMind Biomedical 's novel neurosurgical endoscope, the Axonpen System, has completed its First in Man (FIM) clinical trial in Taiwan with outstanding results. The Axonpen System which received US FDA 510 (k) clearance in 2020 and from the Taiwan FDA in 2021, is ...